On October 31, 2017, the Board of Directors of Cambrex Corporation appointed Dr. Gregory B. Brown, M.D. as a member of the company's Board of Directors for a term expiring on the date of its 2018 annual meeting. He will serve on the Audit and Regulatory Affairs Committees. Dr. Brown's appointment increases the size of the Board to 10 members. Dr. Brown currently serves as Chairman of the Board of Caladrius Biosciences Inc. He is also a member of the Board and Audit Committee of Faron Pharmaceuticals, Oy, as well as a member of the Board, Audit, Governance and Product Selection Committees of MonoSol Rx, LLC. Dr. Brown also serves on the Board of Vanderbilt Clinical S.a.r.l.